跳至主要内容
临床试验/NCT01333384
NCT01333384已完成不适用

A Non-Interventional Retrospective (12 Months) and Prospective (at Least 24 Months) Resource Utilization Study, in the Population of Polish Acromegalic Patients Treated With Somatuline Autogel at Normal (4 Weeks) or Extended (6 or 8 Weeks) Dosing Interval

Ipsen1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Ipsen
入组人数
150
试验地点
1
主要终点
Percentage variation of Insulin-like growth factor-1 (IGF-1) levels

研究概览

简要总结

The purpose of this study is to evaluate over the 24 month prospective follow up - in everyday clinical practice - resource utilization and effectiveness of the treatment of acromegalic patients in Poland with Somatuline Autogel 120 mg including extended injection intervals.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients with acromegaly treated for at least three injections with Somatuline Autogel 120 mg
  • Subjects must be treated for acromegaly for at least 1 year, with medical treatment prior to inclusion. One year historical data must be available

排除标准

  • Active participation in any interventional or any other non-interventional acromegaly clinical study. Previous participation in observational / post-marketing study of other somatostatin analogue should not be an exclusion criteria

结局指标

主要结局

Percentage variation of Insulin-like growth factor-1 (IGF-1) levels

时间窗: 24 months

次要结局

  • Proportion of patients with GH levels below 1.0 microgram/liter(24 months)
  • Mean growth hormone (GH) levels(24 months)

研究者

发起方
Ipsen
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study in Polish Acromegalic Patients Treated With... | 临床试验